FTZ attenuates liver steatosis and fibrosis in the minipigs with type 2 diabetes by regulating the AMPK signaling pathway - 16/04/21
páginas | 11 |
Iconografías | 9 |
Vídeos | 0 |
Otros | 0 |
Abstract |
Fufang Zhenzhu Tiaozhi formula (FTZ), a preparation of Chinese herbal medicine, has various pharmacological properties, such as hypoglycemic, hypolipidemic, anticoagulant, and anti-inflammatory activities. Hepatocyte apoptosis is a marker of nonalcoholic steatohepatitis (NASH) and contributes to liver injury, fibrosis, and inflammation. Given the multiple effects of FTZ, we investigated whether FTZ can be a therapeutic agent for NASH and its mechanism. In the present study, we observed that FTZ treatment had an obviously favorable influence on hepatic steatosis and fibrosis in the histopathologic features of type 2 diabetes mellitus (T2DM) and coronary heart disease (CHD) with NASH minipigs. In addition, immunohistochemical analysis showed increased expression of the fibrotic marker α-smooth muscle actin (α-SMA), and a TUNEL assay revealed increased apoptotic positive hepatic cells in the liver tissues of the model group. Furthermore, FTZ administration reduced the increased expression of α-SMA, and FTZ inhibited apoptosis by affecting Bcl-2/Bax and cleaved caspase-3 expression. Mechanistically, our data suggested that FTZ treatment attenuated hepatic steatosis and fibrosis via the adenosine monophosphate-activated protein kinase (AMPK) pathway. In vitro studies showed that FTZ also attenuated intracellular lipid accumulation in HepG2 cells exposed to palmitic acid (PA) and oleic acid (OA). FTZ upregulated the expression levels of P-AMPK and BCL-2 and downregulated BAX. The changes induced by FTZ were reversed by Compound C, an inhibitor of AMPK. In conclusion, FTZ attenuated NASH by ameliorating steatosis and hepatocyte apoptosis, which is attributable to the regulation of the AMPK pathway.
El texto completo de este artículo está disponible en PDF.Graphical Abstract |
Highlights |
• | FTZ attenuates NASH in minipigs with T2DM and CHD by ameliorating steatosis, apoptosis and fibrosis. |
• | FTZ might improve lipid overaccumulation in HepG2 cells. |
• | FTZ reduces hepatocytic lipid accumulation and apoptosis partially through the AMPK pathway. |
Abbreviations : AMPK, ALT, AST, BCA, BMI, CHD, DMEM, FPG, FTZ, GLU, H&E, HDL-C, HFD, HRP, LDL-C, NAFLD, NASH, ND, IVGTT, INS, OA, PBS, PA, PVDF, TC, TG, T2DM, α-SMA
Keywords : Nonalcoholic steatohepatitis, Fufang Zhenzhu Tiaozhi, Fibrosis, Steatosis, Apoptosis, AMPK
Esquema
Vol 138
Artículo 111532- juin 2021 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
La compra de artículos no está disponible en este momento.
¿Ya suscrito a @@106933@@ revista ?